Study sheds light on the possible role of estradiol in cognitive decline and Alzheimer's disease
Recent investigations have focused on the effect of serum estradiol levels on cognitive abilities among older women. Estradiol, a prominent sex steroid hormone, has been associated with the development of Alzheimer's disease (AD) and cognitive decline. A study led by Xu et al. utilized data from the National Health and Nutrition Examination Survey (NHANES) 2013-2014 to delve deeper into this relationship. The research included 731 women aged 60 and older who met established criteria for inclusion. Estradiol levels were assessed using advanced techniques, and cognitive performance was measured through several standardized tests.
Serum estradiol methodology for cognitive assessment
The researchers divided serum estradiol levels into three tertiles: T1 with levels below 3.68 pg/mL, T2 with levels between 3.68 and 7.49 pg/mL, and T3 with levels exceeding 7.49 pg/mL. Cognitive function was evaluated using the Vocabulary Learning Subtest (CERAD), the Animal Fluency Test (AFS), and the Digital Symbol Substitution Test (DSST). The analysis revealed that the average age of participants was 69.57 years, with a majority being non-Hispanic white and possessing at least some college education.
The average serum estradiol level across the sample was recorded at 8.48 pg/mL. The findings indicated that higher serum estradiol levels correlated with enhanced scores on the DSST, suggesting improvements in processing speed, sustained attention, and working memory among participants in the highest estradiol category. Specifically, a unit increase in estradiol levels corresponded with a significant rise in DSST scores within the T3 group. However, no substantial correlations were observed between serum estradiol levels and scores from the CERAD and AFS tests, highlighting a complex interaction between hormone levels and different facets of cognitive function.
Relevance to Alzheimer’s disease and cognitive function
The implications of these findings extend beyond cognitive testing alone. The influence of sex steroids, particularly estrogen, on cognitive functions such as memory and learning is well-established. Previous studies have demonstrated that estrogen can offer neuroprotective effects, enhance synaptic plasticity, and serve as a potential preventive strategy against neurodegenerative diseases like Alzheimer’s. The Kronos Early Estrogen Prevention Study (KEEPS) has indicated that transdermal estradiol therapy may reduce amyloid-beta deposition in the brain, particularly among individuals at genetic risk for Alzheimer’s due to the presence of the apolipoprotein E (APOE) E4 allele.
Furthermore, estrogen seems to play a protective role in preserving brain health, especially when administered around the time normal endogenous hormone production ceases. However, research suggests that if too much time elapses after the natural decline of estrogen before hormone replacement is initiated, the potential benefits may be considerably diminished.
Understanding the intricate connections between serum estradiol levels and cognitive function in older women is crucial as society faces an increasing prevalence of cognitive decline and dementia. The exploration of how hormonal fluctuations impact cognition could pave the way for innovative treatments and preventative strategies. Future studies should continue to explore the effects of estrogen on brain health, offering promising avenues for enhancing cognitive aging and strategies for preventing Alzheimer's disease. Moreover, the role of estrogen has been assessed not only in maintaining cognitive function in non-demented women but also in the prevention and treatment of AD.
Stay informed about the medical and local news in Miami by subscribing to the Calle Ocho News newsletter. If you wish to promote your business to Miami’s vibrant community, Calle Ocho News provides advertising solutions to help you engage with a broad and active audience.
Add Comment